SynCore Biotechnology to Participate at the BIO-EUROPE SPRING – 12th Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the BIO-EUROPE SPRING – 12th Annual International Partnering [...]
Syncore Biotechnology to Participate at the Biotech Showcase 2018 Conference
Syncore Biotechnology will attend the Biotech Showcase 2018 Conference on January 8-10th (https://ebdgroup.knect365.com/biotech-showcase/) in San Francisco, [...]
SynCore Biotechnology to Participate at the BIO-Europe 2017 – 23rd Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the BIO-Europe 2017 - 23rd Annual International Partnering [...]
SynCore Biotechnology Receives Investigational New Drug (IND) Clearance of SB05 PC by the Taiwan Food and Drug Administration (TFDA) to Conduct a Phase III Clinical Trial for the Treatment of Metastatic Adenocarcinoma of the Pancreas
Investigational New Drug (IND) clearance from TFDA represents a key milestone in SynCore’s new drug [...]
SynCore Bio to present the Phase I study of SB01 at ASCO 2017
SynCore Biotechnology Co., Ltd. (SynCore) is selected to present the Phase I study of SB01 [...]
SynCore Biotechnology Receives Investigational New Drug (IND) Clearance of SB05 PC by the US Food and Drug Administration (FDA) to Conduct a Phase III Clinical Trial for the Treatment of Metastatic Adenocarcinoma of the Pancreas
• Investigational New Drug (IND) clearance from US FDA represents a key milestone in SynCore’s [...]
SynCore Bio is selected to present the Phase I study data of new anti-cancer molecule SB01 at ASCO 2017
SynCore Bio is selected to present the Phase I study data of new anti-cancer molecule [...]
2017 Sinphar Bio-Forum – Cardiovascular Disease Management
On January 13th of this year, Sinphar Group held the 3rd Biomedical Forum in grand [...]
SynCoreBio Signs Contract with Swiss Company Y-YBar To Jointly Develop Precision Instruments for the Diagnosis of Eye Diseases
SynCore Biotechnology Co. Ltd. (4192) signed a global contract today (11/8) with Swiss optical instruments [...]
SynCoreBio significance progress in the negotiations of cooperation strategy. Breakthrough the predominance and maximizing the value of technology platform!
SynCoreBio together with its strategic partner German company Medigene (MG) announced today (December 17 2015) for [...]
Related Link
Taiwan Food and Drug Administration,Department of Health
Medical and Pharmaceutical Industry Technology and Development Center
Center for Drug Evaluation(CDE), Taiwan
Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)
Development Center for Biotechnology
Institute for Biotechnology and Medicine Industry
Pharmaceutical Research and Manufacturers of America
International Federation of Pharmaceutical Manufacturers Associations (IFPMA)